Eagle Pharmaceuticals, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$55.32M
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
EGRX · price snapshotP/E 0.28x
$0.76Snapshot Sep 9, 2026, 8:00 PM ET
Implied fair value · at WMT's multiple
$111.4114,656.3% above market
2.73 EGRX Annual EPS×40.81x WMT P/E=$111.41
Market $0.76Implied $111.41
WMT · price snapshotP/E 40.81x
$111.41Close Dec 31, 2025
Implied fair value · at EGRX's multiple
$0.7699.3% below market
2.73 WMT Annual EPS×0.28x EGRX P/E=$0.76
Market $111.41Implied $0.76